Socio-economic impact of reducing the duration of untreated psychosis
Submitting Institution
University of ManchesterUnit of Assessment
Psychology, Psychiatry and NeuroscienceSummary Impact Type
PoliticalResearch Subject Area(s)
Medical and Health Sciences: Clinical Sciences, Public Health and Health Services
Summary of the impact
People who develop psychosis (1% of population) typically experience
lengthy delays (months to years) before treatment. Researchers at the
University of Manchester (UoM) established a concrete and significant
association between delay in treatment of the first episode of psychosis
and outcome. We demonstrated that outcome of psychosis could be improved
considerably if these lengthy delays were reduced. This research
influenced policy and practice in the UK and abroad. Policy changes
included the establishment of early psychosis teams dedicated to early
detection and treatment (50 in England alone). Practice changes included
amendments to clinical guidelines in the UK and abroad that now require
clinicians to respond urgently to a first episode of psychosis. These
changes to clinical practice have increased the proportion of patients
with a short DUP from 55.6 to 77.4%.
Underpinning research
See section 3 for references 1-6. UoM researchers are given in bold.
The impact is based on research that took began at UoM in 1995 and
continues to date. The research was part of a continuing programme of work
on early psychosis, funded by the Department of Health (DH), the Medical
Research Council and the National Institute of Health Research, which has
included: systematic reviews, clinical trials, follow-up studies and
qualitative studies. The first major publication was in 2000. The key
researchers were:
-
Max Marshall (Senior Lecturer, 1995-2001; Professor, 2001-date)
-
Shôn Lewis (Professor, 1994-date)
-
Richard Drake (Clinical Research Fellow, 1996-2001; Clinical
Lecturer, 2002-2004; Senior Lecturer, 2004-date)
-
Austin Lockwood (Research Nurse, 1995-2007)
-
Shahid Akhtar (Clinical Lecturer, 1995-2001)
-
Clifford J Haley (Clinical Lecturer, 1995-2001)
Our research focussed on the duration of untreated psychosis (DUP) in
determining the prognosis of schizophrenia. DUP is the time from the
appearance of the first psychotic symptom until initiation of adequate
treatment. For many years debate raged in the research community between
those who believed that untreated psychosis was harmful (in the sense of
actually causing permanent damage to the chances of recovery from
psychosis) and those who did not. The importance of the debate rested on
the fact that if DUP were indeed harmful, then reducing it would be a key
way to improve the outcome of an otherwise intractable and expensive
condition.
Our research settled this debate by demonstrating a clear association. In
2000, we published our first contribution by reporting results from a
large cohort study (SOCRATES) funded by the Medical Research Council (1).
This research established a strong association between DUP and outcome,
and indicated that prognosis was most likely to be improved by urgent
intervention. In 2003, we published an expert briefing paper for the DH
(2), followed by a narrative review (3) and then a systematic review and
meta-analysis of 26 prospective cohort studies involving 4490 first
episode patients (4) (funded by NHS nationally commissioned R&D;
£43,000, Principal Applicant: Marshall). Our systematic review
categorically demonstrated a significant association between DUP and
outcomes, including: remission of all symptoms; severity of persistent
symptoms (especially, delusions, hallucinations and thought disorder); and
social functioning.
We also demonstrated that the association between DUP and outcome was
present in both the short and long term. Our findings were subsequently
confirmed by other researchers and have been summarised in the main
international handbook for clinicians working in early psychosis (5). In a
more recent review, with our Dutch collaborators, we have also
demonstrated an association between DUP and negative symptoms (6).
References to the research
Our research is well documented and highly cited in the top tier of
international peer-reviewed journals. For example: in terms of citations,
publication 4 is ranked 14th of 1186 papers published in Archives
of General Psychiatry from 2005-11.
1. Drake RJ, Haley CJ, Akhtar S, Lewis SW. Causes and
consequences of duration of untreated psychosis in schizophrenia. The
British Journal of Psychiatry. 2000;177(6):511-5. DOI:
10.1192/bjp.177.6.511
3. Norman RMG, Lewis SW, Marshall M. Duration of untreated
psychosis and its relationship to clinical outcome. The British
Journal of Psychiatry. 2005;187(48):s19-s23. DOI:
10.1192/bjp.187.48.s19
4. Marshall M, Lewis S, Lockwood A, Drake R, Jones P,
Croudace T. Association between duration of untreated psychosis and
outcome in cohorts of first-episode patients: A systematic review. Archives
of General Psychiatry. 2005;62(9):975-83.
DOI:10.1001/archpsyc.62.9.975
5. Marshall M, Harrigan S, Lewis S. Duration of Untreated
Psychosis: Definition, Measurement and Association with Outcome. In:
McGorry P, Jackson H, editors. The Recognition and Management of Early
Psychosis: A preventive approach. 2nd ed. Cambridge: Cambridge
University Press; 2009. pp. 125-46. Available from UoM on request.
6. Boonstra N, Klaassen R, Sytema S, Marshall M, De Haan L,
Wunderink L, Wiersma D. Duration of untreated psychosis and negative
symptoms: A systematic review and meta-analysis of individual patient
data. Schizophrenia Research. 2012;142(1-3):12-9. DOI:
10.1016/j.schres.2012.08.017
Details of the impact
See section 5 for corroborating sources S1-S10.
Context
Psychosis is a serious mental illness characterised by delusions,
hallucinations, disordered thinking, disturbed behaviour and poor social
functioning. Psychosis is common; about 1% of the population develop
psychosis in their lifetime, mostly before the age of 35. Often psychosis
becomes a chronic condition and it has substantial economic and social
costs. For example, it reduces life expectancy by 15-20 years and costs
the UK economy £6.7 billion per year. Typically people who develop
psychosis experience lengthy delays (months to years) before receiving
treatment. Our research has indicated that the outcome of psychosis could
be considerably improved if these lengthy delays were reduced.
Pathways to impact
Our research has arrived at its impact, in the UK and abroad, by
influencing:
(a) national policies that funded early psychosis services to reduce DUP;
(b) national clinical guidelines that emphasised the need for clinical
services to target reductions in DUP;
(c) radical changes in aspects of best clinical practice at the level of
the individual clinician.
Reach and significance of the impact
Impact on mental health policy, leading to improved outcomes
a) England
Our research was presented to the DH during the implementation of the NHS
Plan (2000). The NHS Plan required the establishment of 50 early psychosis
services covering the whole of England. A member of the DH mental health
policy team (2004-12) confirms that `[t]he research demonstrating the
linkage between shorter DUPs and better outcomes was a crucial
underpinning of the policy case for early intervention services.' (S1) The
research thus contributed to what is described as `a huge expansion in
early intervention services' between 2000 and 2008, `so that by 2008 the
planned comprehensive coverage set out in the NHS Plan of 2000 had been
achieved.' (S1) The advisor confirms that support for early intervention
services has been maintained under the current government, as evidenced in
the cross-government mental health outcomes strategy published in 2011
(S2). The Chair of the Early Intervention in Psychosis (IRIS) Network,
which brings together elected regional early intervention leads, also
underlines the importance of the research to recent service development:
`The strengthening evidence base which correlates DUP with improved
outcomes has been vital in energising the whole direction of service
development' (S3). The 2012 IRIS Guidelines, which cite our research,
describe in detail how to organise an Early Intervention Service and are
endorsed by Rethink, the national mental health charity and the NHS
Confederation (S3). In 2010-11 in England alone, Early Intervention Teams
served 10,311 new cases of psychosis. Independent research into the
economic impact of Early Intervention Services in England has shown a
saving of £4972 per year per person treated, due to better outcomes (S4).
Our Expert Briefing Paper (2) was also utilised by the DH in support of
one of the key targets of the NHS Plan: reducing DUP to a median of 3
months. Our research from the National Eden project, a large, multi-centre
follow up study of new patients being cared for by early intervention
teams, shows that as early intervention services are introduced the
proportion of patients with a short DUP increases from 55.6 to 77.4% (Marshall
et al., 2013, submitted) (S5).
The DH requires the reporting of DUP as part of the National Mental
Health Minimum Dataset for all NHS Mental Health Trusts.
As a result of the strong link between DUP and outcome, the DH is
considering using DUP as a metric in the Quality and Outcomes Framework
for Payment by Results. This would ensure that NHS Trusts have a strong
financial incentive to respond quickly to a first episode of psychosis. Marshall
has been acting as an advisor in these deliberations (S1).
b) International reach
The Australian Government's Department of Health and Ageing cited our
research in its Early Psychosis Feasibility Study Report, which underpins
the Fourth National Mental Health Plan 2009-14. The Australian Government
allocates $AUS 220 million to fund early detection of psychosis services
under the 2009-14 National Mental Health Plan (S6).
The US National Institute of Mental Health (NIMH) is considering a
national programme to reduce DUP and is currently issuing calls for
research into the impact of reducing DUP. Marshall is acting as
advisor. The director of the Division of Services and Intervention
Research at the NIMH confirms that the NIMH committed $US 2m in the fiscal
year 2013 to support initiatives to test reproducible strategies to reduce
DUP among those with first episode psychosis in the USA, with plans to
commit similar sums for research into DUP in the fiscal years 2014 and
2015. It is noted that the `seminal meta-analysis of DUP studies (2005)'
(ref 4 above) is cited in both recent funding calls (S7).
State Governments in Canada that are promoting Early Intervention
Services have cited our research in policy documents, for example the
Ontario Programme Standards for Early Intervention (S8). This
document acknowledges the contribution of the UoM research, noting that
`There is evidence that longer DUP is associated with poorer outcome once
treatment is initiated (Marshall et al., 2005' [reference 4 above];
Norman et al., 2005)' (p.6). It then identifies as a key objective the
need to `reduce the duration of untreated psychosis through early and
appropriate detection and response, thereby potentially reducing the
severity of the illness' (p. 7).
Impact on clinical guidelines and practice
a) England
Our research is cited in the British Association for Psychopharmacology
guidelines for the treatment of schizophrenia. New NICE National
Schizophrenia Guidelines for Adults (CG82, 2013; currently out for
consultation) now recognise the importance of prompt treatment of
first-episode schizophrenia. Marshall is a member of the
Guidelines Development Group, invited for his expertise in this area. Our
research is also cited in the NICE guidelines on Psychosis and
Schizophrenia in Young People (CG155, 2013). The director of the National
Collaborating Centre for Mental Health writes that Marshall
`demonstrated that the clinical outcomes for people following a first
episode of psychosis, even up to 15 years later, were harmed by there
being a prolonged period during which no treatment was provided. [Marshall's]
paper also highlighted the possibility that the early period of psychosis
is the most important period during which most of the long term harm
associated with psychoses occurs. This understanding, that the duration of
untreated psychosis correlates with worse outcomes for people with first
episode psychosis, has been highly influential on our overall approach to
the treatment of first episode psychosis and on the recommendations for
the suite of NICE guideline[s] identified above [CG82, 2013; CG155, 2013].
The duration of untreated psychosis has, since this paper and the various
guidelines have been published, fallen substantially'. (S9) Clinicians
working in the NHS are required to abide by the NICE guidelines described
above.
b) International reach
The research has been cited in: the Italian national guidelines for early
intervention in schizophrenia; the World Federation of Societies of
Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of
Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia
and the management of treatment resistance; and the National Guidelines
for prevention of mental disorders in children issued by National Research
Council and Institute of Medicine of the National Academies in United
States (S10).
At least 117 professional articles around the world (e.g., Russia,
Germany, France, Spain, Japan and the USA) draw on our review to advocate
a more urgent response to first episode psychosis. The key international
textbook on the clinical management of first episode psychosis devotes a
chapter to our research. It is also cited as critical evidence in the Clinical
Manual of Prevention in Mental Health (Compton 2009): `DUP is
recognized as a critical variable in the light of evidence associating
longer DUP with poorer outcomes...Marshall and colleagues (2005)...
found a significant association' (p. 144).
Sources to corroborate the impact
Sources available from UoM on request.
S1. Corroborating statement from team member, mental health policy team,
2004-2012.
S2. HM Government/Department of Health. No Health without Mental
Health: A Cross-Government Mental Health Outcomes Strategy for People of
All Ages (2011).
S3. Corroborating letter from Chair of IRIS network, GP and carer; IRIS
Guidelines (2012).
S4. Department of Health. Chief Nursing Officer Bulletin, 26 June 2012.
S5. Marshall M, et al. The National Eden Study — Impact of
introducing early intervention teams on the duration of untreated
psychosis: prospective cohort analysis (submitted 2013).
S6. Australian Government Department for Health and Ageing, Early
Psychosis Feasibility Study Report (2011); Australian Government, Budget
2011-12, Budget Paper No.3, Part 2: Payments for Specific Purposes —
Health.
S7. Corroborating email from the Director, Division of Services and
Intervention Research, National Institute of Mental Health (Washington,
USA) on impact on policy making at NIH.
S8. Early Psychosis Intervention Program Standards, Ontario Ministry of
Health and Long-Term Care. 2011.
S9. Corroborating email from the Director, National Collaborating Centre
for Mental Health, Royal College of Psychiatrists, Medical Director and
Consultant Psychiatrist, Sheffield Health and Social Care NHS Foundation
Trust.
S10. De Masi S, et al. The Italian guidelines for early intervention in
schizophrenia: development and conclusions. Early Intervention in
Psychiatry. 2008; 2(4): 291-302; World Federation of Societies of
Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of
Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia
and the management of treatment resistance. The World Journal of
Biological Psychiatry. 2012;13(5):318 -378; Committee on the
Prevention of Mental Disorders and Substance Misuse Among Children, Youth
and Young Adults, O'Connell ME et al., editors. Preventing Mental,
Emotional, and Behavioral Disorders Among Young People. Washington:
The National Academies Press; 2009.